Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal
Disease Category: Rheumatoid Arthritis
Trial Information
Do You Have Rheumatoid Arthritis?
Now Enrolling
Clinical Research Study for Adults with Rheumatoid Arthritis
The purpose of this study is to demonstrate that subcutaneous injections of abatacept (Orencia) are as effective as intravenous infusions of abatacept (Orencia) when used together with methotrexate in subjects with active rheumatoid arthritis. Like intravenous administration of abatacept, subcutaneous administration of abatacept may reduce the signs and symptoms of rheumatoid arthritis by controlling the activity of cells in the immune system. There is no placebo in this study, everyone receives either intravenous or subcutaneous abatacept.
Patient Inclusion:
- Must be 18 years of age or older
- Must have been diagnosed with rheumatoid arthritis
- Must have been treated with rheumatoid arthritis medications in the past
- Must be willing to have weekly injections of the study drug, either self-injected or administered by a caregiver
Patient Exclusion: None listed
John J. Condemi, M.D., Medical Director
AAIR Research Center
300 Meridian Centre, Suite 305
Rochester, NY 14618
Phone: 585-442-1980
Fax: 585-442-1585
EMail: research@aair.info
View Google Map
Research Center Information: AAIR Research Center
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
